2-210656523-A-G
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001875.5(CPS1):c.3559-2A>G variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.000000718 in 1,393,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001875.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- carbamoyl phosphate synthetase I deficiency diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CPS1 | NM_001875.5 | c.3559-2A>G | splice_acceptor_variant, intron_variant | Intron 29 of 37 | ENST00000233072.10 | NP_001866.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CPS1 | ENST00000233072.10 | c.3559-2A>G | splice_acceptor_variant, intron_variant | Intron 29 of 37 | 1 | NM_001875.5 | ENSP00000233072.5 |
Frequencies
GnomAD3 genomes Cov.: 26
GnomAD2 exomes AF: 0.00000819 AC: 2AN: 244142 AF XY: 0.0000151 show subpopulations
GnomAD4 exome AF: 7.18e-7 AC: 1AN: 1393584Hom.: 0 Cov.: 33 AF XY: 0.00000144 AC XY: 1AN XY: 696328 show subpopulations
GnomAD4 genome Cov.: 26
ClinVar
Submissions by phenotype
Congenital hyperammonemia, type I Pathogenic:2
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has been observed in individual(s) with carbamoyl phosphate synthetase I deficiency (PMID: 21120950). ClinVar contains an entry for this variant (Variation ID: 552522). This variant is present in population databases (rs766584384, ExAC 0.002%). This sequence change affects an acceptor splice site in intron 29 of the CPS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in CPS1 are known to be pathogenic (PMID: 21120950). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at